Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Gah Intervention

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed1
Enrolling By Invitation1
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07804095Not ApplicableEnrolling By InvitationPrimary

AI-Supported Care Engagement for Next-step Delivery - Medicare Advantage

NCT07587073Not ApplicableNot Yet Recruiting

Comprehensive Enhanced Care Management Under CalAIM for High-Risk Medi-Cal Members

NCT04547374WithdrawnPrimary

Evaluation of Geisinger at Home (GaH) Patient Management

NCT00365885Not ApplicableCompleted

Showing Health Information Value in a Community Network

Showing all 4 trials

Research Network

Common Treatments

  • Gah Intervention1
  • Comprehensive Calaim Care Bundle1
  • Computerbased Clinical Decision Support1
  • Usual Calaim Service Delivery1
  • Aisupported Risingrisk Care Navigation1

Active Sponsors

  • Duke University1
  • StratiHealth1
  • Intermountain Health Care, Inc.1
  • Geisinger Clinic1

Top Investigators

Related Conditions

  • Clinical Decision Support1
  • Patient Navigation1
  • Medical Informatics Interventions1
  • Quality Of Healthcare1
  • Postacute Care Utilization1

Activity Timeline